TW496862B - Recovery of epsi-caprolactam - Google Patents
Recovery of epsi-caprolactam Download PDFInfo
- Publication number
- TW496862B TW496862B TW086101201A TW86101201A01A TW496862B TW 496862 B TW496862 B TW 496862B TW 086101201 A TW086101201 A TW 086101201A TW 86101201A01 A TW86101201A01 A TW 86101201A01A TW 496862 B TW496862 B TW 496862B
- Authority
- TW
- Taiwan
- Prior art keywords
- alcohol
- caprolactam
- aqueous
- phase
- aminohexamidine
- Prior art date
Links
Landscapes
- Polyamides (AREA)
Abstract
Description
496862 Α7 Β7 五、發明説明(1 ) 本發明係關於使6 —胺基己醯胺及6 -胺基己醯胺寡聚 物與ε—己內醯胺相分離之方法。 此方法係得知自US—A- 5495016,此專利申請案揭 示經由蒸餾法使ε -己內醯胺與其尼龍一 6寡聚物分離。 蒸餾的缺點是ε—己內醯胺將部份轉化成更多的寡聚物 (根據US — A — 5495016實例1爲2重量%絕對量),另一個 缺點是因爲存在於蒸餾殘留物中的寡聚物固化而阻塞管線 及其他製程設備。 本發明之目的是提供使6 -胺基己醯胺及6 -胺基己醯 胺寡聚物與ε —己內醯胺相分離之方法,其中沒有損失ε — 己內醯胺。 經濟部中央標準局員工消費合作社印裝 - - =—·LI: ----- ,Tt - ...... 111·· I # (請先閱讀背面之注意事項再填寫本頁) 此目的之達成是其中ε -己內醯胺、6 —胺基己醯胺及 6 —胺基己醯胺寡聚物係存在於第一個水性起始混合物 中,此混合物與醇萃取溶劑接觸,導致含少量ε-己內醯 胺之第一個水性殘留相及含大量ε -己內醯胺之醇相,且 在醇相中含6_胺基己醯胺及/或6-胺基己醯胺寡聚 物,其中後者的醇相隨後與水(逆流水)接觸蓴致含少量6 一胺基己醯胺及/或6-胺基己醯胺寡聚物的醇萃取相及 含大量6 —胺基己醯胺及/或6 -胺基己醯胺寡聚物的第 二個水性殘留相。 頃經發現實施根據本發明之方法,可成功地使6 -胺 基己醯胺及6 -胺基己醯胺寡聚物與ε -己内醯胺相分 ΕΡ — Α — 729944揭示ε —己內醯胺可經由萃取法用二 本紙張尺度適用中國國家標準(CNS ) A4規格(210 X 297公釐)-4 - 496862 A7 —____B7_ 五、發明説明泛) 氯甲烷、環己烷、甲苯、苯、氯仿或三氯乙烷從同時含6 一胺基己醯胺寡聚物的水性混合物中回收,此專利申請案 沒有說明用醇溶劑作爲萃取劑,頃經發現EP — A - 729944 的最有效萃取溶劑爲舉例的氯化溶劑,但是這些溶劑因爲 環境的因素而較不宜使用。 NL - A - 6803 152揭示用C4 一 CM環)脂族醇從水性混 合物萃取ε—己內醯胺的實例,此專利申請案沒有揭示在 水性混合物中存在6—胺基己醯胺或其寡聚物,而且沒有 揭示用水進行第二次萃取。 第一個水性起始混合物中也可含6 —胺基己酸及6 -胺 基己酸寡聚物,此混合物爲例如得自EP - Α — 729944的 方法,頃經發現這些化合物當進行根據本發明之方法時, 可有效地與ε—己內醯胺分離。 此寡聚物通常是6 -胺基己酸或6 -胺基己醯胺的二聚 物及三聚物,更高的寡聚物可存在爲更低的含量。 在第一個水性混合物中寡聚物的濃度較宜高於0.5重量 %,更宜不超過10重量%。 ~ 在第一個水性混合物中ε —己內醯胺、6 —胺基己酸、 6 —胺基己醯胺及寡聚物的濃度較宜爲5- 50重量%,且 更宜爲10 — 35重量%,ε-己內醯胺的濃度較宜爲5 — 30 重量%,6 -胺基己醯胺的濃度較宜爲0.1至10重量%,6 一胺基己酸的濃度較宜爲0.1至1〇重量%。 醇萃取溶劑較宜爲實質上不溶於第一個水性混合物的 溶劑,在此實質上不溶係指醇溶劑與水性混合物的混合$ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐)-5 - 請 先 閱 讀 背 ιέ 之 注 意 事 項 再496862 Α7 B7 V. Description of the invention (1) The present invention relates to a method for separating 6-aminohexamidine and 6-aminohexamidine oligomers from ε-caprolactam. This method is known from US-A-5,950,016. This patent application discloses the separation of ε-caprolactam from its nylon-6 oligomer by distillation. The disadvantage of distillation is that ε-caprolactam converts part of it into more oligomers (2% by weight in absolute terms according to US-A-5495016 Example 1). Another disadvantage is that it is present in the distillation residue. Oligomers solidify and block pipelines and other process equipment. The object of the present invention is to provide a method for phase separation of 6-aminohexamidineamine and 6-aminohexamidineamine oligomers from ε-caprolactam, without loss of ε-caprolactam. Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs--=-· LI: -----, Tt-...... 111 ·· I # (Please read the precautions on the back before filling this page) This The objective is achieved in which ε-caprolactam, 6-aminohexamidine and 6-aminohexamidine oligomers are present in the first aqueous starting mixture, and this mixture is contacted with an alcohol extraction solvent, Resulting in the first aqueous residual phase containing a small amount of ε-caprolactam and the alcohol phase containing a large amount of ε-caprolactam, and in the alcohol phase containing 6-aminohexanamine and / or 6-aminohexanone Ammonium oligomers, in which the alcohol phase is subsequently contacted with water (counter-current water), resulting in alcohol-extracted phases containing a small amount of 6-aminohexamidine and / or 6-aminohexamidine oligomers and a large amount of A second aqueous residual phase of 6-aminohexamidine amine and / or 6-aminohexamidine oligomer. It has been found that the implementation of the method according to the present invention can successfully separate the 6-aminohexamidine amine and 6-aminohexamidine oligomers from the ε-caprolactam phase. EP-Α-729944 reveals ε -hexanox Lentamine can be extracted by the two paper sizes applicable to the Chinese National Standard (CNS) A4 specifications (210 X 297 mm) -4-496862 A7 —____ B7_ by the extraction method. 5. Chloroform, cyclohexane, toluene, Benzene, chloroform, or trichloroethane was recovered from an aqueous mixture that also contained 6-aminohexamidine oligomers. This patent application did not describe the use of an alcohol solvent as an extractant. Effective extraction solvents are exemplified chlorinated solvents, but these solvents are less suitable for environmental reasons. NL-A-6803 152 discloses an example of extracting ε-caprolactam from an aqueous mixture using a C4 -CM ring) aliphatic alcohol. This patent application does not disclose the presence of 6-aminohexamidine or its oligo in an aqueous mixture. Polymer and it was not disclosed that a second extraction with water was performed. The first aqueous starting mixture may also contain 6-aminohexanoic acid and 6-aminohexanoic acid oligomers. This mixture is, for example, a method obtained from EP-A-729944. These compounds were found to be based on In the method of the present invention, it can be effectively separated from ε-caprolactam. This oligomer is usually a dimer and trimer of 6-aminohexanoic acid or 6-aminohexamidine. Higher oligomers may be present at lower levels. The concentration of the oligomer in the first aqueous mixture is preferably higher than 0.5% by weight, and more preferably not higher than 10% by weight. ~ The concentration of ε-caprolactam, 6-aminocaproic acid, 6-aminocaproamide and oligomers in the first aqueous mixture is preferably 5-50% by weight, and more preferably 10- 35% by weight, the concentration of ε-caprolactam is more preferably 5-30% by weight, the concentration of 6-aminohexamidine is more preferably 0.1 to 10% by weight, and the concentration of 6-aminohexanoic acid is more preferably 0.1 to 10% by weight. The alcohol extraction solvent is preferably a solvent that is substantially insoluble in the first aqueous mixture. Here, the term “substantially insoluble” refers to a mixture of an alcohol solvent and an aqueous mixture. -5-Please read the precautions before reading
經濟部中央標準局員工消費合作社印製 496862 Α7 Β7 五、發明説明0 ) 在萃取溫度下導致兩個分離的相,在萃取情形下相互間的 溶解度不高於30重量%且更宜低於20重量%。 醇萃取溶劑較宜爲含一或多個羥基的脂族或環脂族化 合物,此醇類較宜含4 - 12個碳原子且較宜含5 - 8個碳 原子,較宜有一或兩個且更宜只有一個羥基存在,較宜使 用位阻的醇類,位阻的醇類爲一種化合物其中羥基鍵結至 一 CWR3其中R1及R2爲烷基且R3爲烷基或氫,此有利於 方法其中所得的水相作爲製備ε -己內醯胺的進料,位阻 的醇類較不會與ε -己內醯胺的Ν -烷基化產物反應。 經濟部中央標準局員工消費合作社印製 (請先閲讀背面之注意事項再填寫本頁) 含兩個羥基的化合物實例爲己二醇、壬二醇、新戊二 醇、甲基一甲基丙二醇、乙基一甲基丙二醇或丁基一甲基 丙二醇,含一個羥基的化合物實例爲環己醇、正丁醇、正 戊醇、2 —戊醇、正己醇、4 一甲基一2 —戊醇、2 —乙基 一 1 —己醇、2 —丙基一 1—庚醇、正辛醇、異壬醇、正 癸醇及直鏈與枝鏈C8-醇類之混合物、直鏈與枝鏈C9-醇 類之混合物及直鏈與枝鏈匕。-醇類之混合物,也可使用 上述醇類之混合物,較佳的醇類對ε -己內醯1安有高親和 力、沸點低於ε -己內醯胺、與水有高密度差、可商業化 供應、與水有低互溶性及/或可生物分解。 逆流水可爲純水或含其他化合物例如醇化合物的水, 較宜使用的水爲至少95重量%純度的水。 第一及第二個水性殘液相可結合成一個水性混合物而 進一步使用,較宜將第一個水性殘液相與水性起始混合物 結合,本方法的此較佳具體實施例較宜在一個方法裝置中 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X297公釐) -6 - 496862 經濟部中央標準局員工消費合作社印製 A7 B7_五、發明説明θ ) 連續進行,此具體實施例的特徵是在一個垂直放置的容器 中進行萃取,其中水性起始混合物在容器的中間位置進 料,醇萃取溶劑進料至容器的底部,且逆流水進料至容器 的頂部,且其中所得的水性殘液及醇萃取相分別在容器的 底部及頂部得到。 醇萃取溶劑及逆流水的量決定於待分離成份的分佈係 數,熟悉此相技藝者可輕易地測定。 萃取步驟是在防止寡聚物沈澱的足夠高溫度下進行, 萃取溫度可通常在室溫至200 °C且較宜在20至170 °C,溫 度介於50至130°C更適宜。 萃取步驟期間的壓力並不重要,且可例如在約0.1 MPa 至約2.0 MPa,且較宜爲約0.1 MPa至約0.5 MPa,此壓力 必須足夠使萃取過程保持液相。 萃取可在習知的萃取裝置中進行,例如逆流管柱、系 列的混合器沈降器、旋轉盤混合器或脈動塡充管柱。 萃取步驟較宜產生含ε-己內醯胺的醇相,其中可含 10 — 40重量%的8 —己內酸胺。 萃取後,可用已知的分離方法將ε—己內醯胺從醇相中 回收,例如蒸餾法及萃取法,蒸餾法較宜用在將其中較低 沸點的醇及醇相中存在的任何水從ε -己內醯胺蒸餾去 除,如此所得的醇溶劑及水較宜在根據本發明的方法中重 複使用。 本發明特別是關於從下列所得的水性混合物中分離ε -己內醯胺,(I)製備ε —己內醯胺的方法其中經由與水反應 本紙張尺度適用中國國家標準(CNS )八4規格(210Χ297公釐) 77 . " (請先閲讀背面之注意事項再填寫本頁) • · _1tPrinted by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 496862 Α7 Β7 V. Description of the invention 0) The two phases that lead to separation at the extraction temperature, in the case of extraction, the mutual solubility is not higher than 30% by weight and preferably lower than 20 weight%. Alcohol extraction solvents are more preferably aliphatic or cycloaliphatic compounds containing one or more hydroxyl groups. The alcohols preferably contain 4 to 12 carbon atoms and more preferably 5 to 8 carbon atoms, more preferably one or two. It is more preferable to have only one hydroxyl group, and it is more suitable to use sterically hindered alcohols. A sterically hindered alcohol is a compound in which the hydroxyl group is bonded to a CWR3 where R1 and R2 are alkyl groups and R3 is an alkyl group or hydrogen, which is beneficial In the method, the obtained aqueous phase is used as a feed for preparing ε-caprolactam, and the hindered alcohols are less likely to react with the N-alkylation product of ε-caprolactam. Printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) Examples of compounds containing two hydroxyl groups are hexanediol, nonanediol, neopentyl glycol, and methyl monomethyl propylene glycol , Ethyl monomethyl propylene glycol or butyl monomethyl propylene glycol, examples of compounds containing one hydroxyl group are cyclohexanol, n-butanol, n-pentanol, 2-pentanol, n-hexanol, 4-methyl 2-pentyl Alcohols, 2-ethyl-1-hexanol, 2-propyl-1-heptanol, n-octanol, isononanol, n-decanol, and mixtures of straight and branched C8-alcohols, straight and branched Mixtures of chain C9-alcohols and straight and branched chains. -Alcohol mixtures, the above-mentioned alcohol mixtures can also be used. The preferred alcohols have a high affinity for ε-caprolactone 1 and a boiling point lower than ε-caprolactam, which has a high density difference with water. Commercial supply, low miscibility with water and / or biodegradable. The counter-current water may be pure water or water containing other compounds such as alcohol compounds, and more preferably water having a purity of at least 95% by weight. The first and second aqueous residual liquid phases can be combined into one aqueous mixture for further use. It is more suitable to combine the first aqueous residual liquid phase with the aqueous starting mixture. This preferred embodiment of the method is more suitable for one The paper size in the method device is applicable to the Chinese National Standard (CNS) A4 specification (210 X297 mm) -6-496862 A7 B7 printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs_5. The description of the invention θ) is carried out continuously, this specific implementation The example is characterized in that the extraction is performed in a vertically placed container, wherein the aqueous starting mixture is fed at the middle position of the container, the alcohol extraction solvent is fed to the bottom of the container, and countercurrent water is fed to the top of the container, and the obtained Aqueous residual liquid and alcohol extraction phases were obtained at the bottom and top of the container, respectively. The amount of alcohol extraction solvent and countercurrent water depends on the distribution coefficient of the components to be separated, and those skilled in this phase can easily determine it. The extraction step is performed at a sufficiently high temperature to prevent oligomer precipitation. The extraction temperature may be usually from room temperature to 200 ° C and more preferably from 20 to 170 ° C, and more preferably from 50 to 130 ° C. The pressure during the extraction step is not critical and may be, for example, from about 0.1 MPa to about 2.0 MPa, and more preferably from about 0.1 MPa to about 0.5 MPa, and this pressure must be sufficient to maintain the liquid phase in the extraction process. The extraction can be performed in a conventional extraction apparatus, such as a countercurrent column, a series of mixer settler, a rotating disc mixer, or a pulsed packed tube column. The extraction step preferably produces an alcohol phase containing ε-caprolactam, which may contain 10-40% by weight of 8-caprolactam. After extraction, ε-caprolactam can be recovered from the alcohol phase by known separation methods, such as distillation and extraction. Distillation is more suitable for the use of lower boiling alcohols and any water present in the alcohol phase. Distillation removal from ε-caprolactam, the alcohol solvent and water thus obtained are preferably reused in the method according to the invention. In particular, the present invention relates to the separation of ε-caprolactam from the aqueous mixture obtained below, (I) a method for preparing ε-caprolactam, in which the Chinese National Standard (CNS) 8-4 specification is applied by reacting with water. (210 × 297 mm) 77. &Quot; (Please read the notes on the back before filling in this page) • · _1t
經濟部中央標準局員工消費合作社印製 496862 A7 ___ ___B7__ 五、發明説明(5 ) 而將6 —胺基己腈轉化成粗ε —己內醯胺,如同揭示在例 如US — A — 5495016 , (II)製備ε —己內醯胺的方法其中經 由在水中使6 —胺基己酸環化,如同揭示在例如US - Α -4730040 ,或(III)其中起始混合物含6 —胺基己酸及6 -胺 基己醯胺,如同揭示在例如EP — A - 729944。 得自方法(I)及(II)的水性混合物也將含有氨氣,其爲從 6 —胺基己腈或6 -胺基己醯胺反應成ε -己內醯胺的副產 物,適宜在萃取前先將氨氣分離,例如用蒸餾法或蒸氣汽 提法,在蒸餾法中,任何未轉化的6 -胺基己腈(方法(I)中) 及部份的水通常將一起被分離,經此氨氣分離後,視需要 含6 —胺基己酸、視需要含6 -胺基己醯胺及寡聚物的所 得水性混合物中,ε -己內醯胺的濃度將較宜大於10重量 % 〇 ε—己內醯胺的反應可連續地進行,在根據本發明的萃 取中所得的水性混合物較宜回收至如同上述(I)、(II)及(III) 的環化製程,頃經發現化合物例如存在於混合物中的6 -胺基己酸、6-胺基己醯胺及寡聚物可在高產率下反應成ε —己內醯胺,因此經由使用萃取法分離ε—己內醯胺,也 可得到有用的回收氣流並能成功地用於製備更多的ε —己 內醯胺,在將水性混合物回收至環化反應區域前,較宜先 將水相中存在的任何醇溶劑分離,此分離較宜用蒸餾法進 行,且更宜用蒸氣蒸餾法。 在製備ε -己內醯胺的一個較佳具體實施例中,係進行 下列步驟:Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 496862 A7 ___ ___B7__ 5. Description of the Invention (5) The conversion of 6-aminocapronitrile to crude ε-caprolactam, as disclosed in, for example, US-A-5495016, ( II) Process for the preparation of ε-caprolactam in which 6-aminocaproic acid is cyclized via water, as disclosed in, for example, US-A-4,730,040, or (III) where the starting mixture contains 6-aminocaproic acid And 6-aminohexamidine, as disclosed in, for example, EP-A-729944. The aqueous mixtures obtained from methods (I) and (II) will also contain ammonia gas, which is a by-product of the reaction of 6-aminohexanonitrile or 6-aminohexamidine amine to ε-caprolactam, suitably at Ammonia is separated before extraction, for example by distillation or steam stripping. In distillation, any unconverted 6-aminocapronitrile (in method (I)) and part of the water are usually separated together. After this ammonia gas separation, the concentration of ε-caprolactam in the resulting aqueous mixture containing 6-aminohexanoic acid and 6-aminohexamidineamine and oligomers if necessary, will preferably be greater than The reaction of 10% by weight εε-caprolactam can be carried out continuously, and the aqueous mixture obtained in the extraction according to the present invention is preferably recovered to the cyclization process as described in (I), (II) and (III) above, It has been found that compounds such as 6-aminohexanoic acid, 6-aminohexamidine and oligomers present in the mixture can be reacted to ε-caprolactam in a high yield, so ε- Caprolactam can also be used to obtain a useful recovery gas stream and can be successfully used to produce more ε-caprolactam. The aqueous mixture is recycled to the reaction zone prior to cyclization, separating any alcohol solvent than in the aqueous phase will be advised, this separation more appropriate to carry out distillation, steam distillation and more is appropriate. In a preferred embodiment for the preparation of ε-caprolactam, the following steps are performed:
本^張尺度適用中國國家標準(€奶)八4規格(210、/297公釐) TgT (請先閱讀背面之注意事項再填寫本頁) ,、訂 496862 A7 B7_ 五、發明説明(6 ) (i) 將含6 -胺基己酸、6 —胺基己醯胺及其個別寡聚物的 水性混合物在液相下,於270至350 °C的反應器中反應成 ε —己內醯胺。 (ii) 將氨氣從所得的水性混合物分離,使其濃度低於〇·1重 量% 〇 (iii) 經由根據本發明的方法從步驟(Π)所得的水性混合物中 萃取ε-己內醯胺,導致形成殘液相及醇萃取液相。 (iv) 使水性殘液相與蒸氣接觸,將任何溶解的醇溶劑從殘 液相中去除。 (v) 將步驟(iv)所得的水性相回收至步驟(i)。 (vi) 從醇相中分離ε -己內醯胺,並將所得的醇溶劑在步驟 (iii)中重複使用。 在步驟⑴的溫度較宜爲270至350 °C,更宜高於290 °C,在步驟⑴的壓力較宜爲5.0至20 MPa,通常壓力將大 於或等於液體反應混合物及使用溫度所得的壓力。 經濟部中央標準局員工消費合作社印製 (請先閱讀背面之注意事項再填寫本頁) 上述具體實施例的可能製程圖例之實例敘述在附圖 1,在附圖1中可看到將水性起始原料⑴進粍至環化反應 器(A),在蒸餾(B)中將氨氣(c)從水性反應器流出物(b)中分 離,將含ε —己內醯胺、6 -胺基己酸、6 —胺基己醯胺及 其個別的寡聚物之所得的水性液體混合物(d)進料至萃取管 柱(C),在此管柱中供應逆流水(g)並同時也供應醇溶劑 (h),所得的醇萃取相(e)進料至蒸餾管柱(D),其中較低沸 點的醇及溶解的水經由⑴與ε-己內醯胺產物⑴分離,在 液體/液體分離器(Ε)中使醇與水分離,導致逆流水(g)(視 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 7〇1 496862 A7 B7 五、發明説明(7 ) 需要含相同的醇)及醇溶劑流(h)(視需要含部份溶解的水), 將水性殘液相⑴進料至蒸氣汽提器(F)其中存在於⑴的任何 醇及任何過量的水經由⑴分離,將含6—胺基己酸、6-胺基己醯胺及其個別的寡聚物與視需要的少量ε-己內醯 胺之所得的水性混合物(k)回收至反應器(Α)。 現在將用下列非限定的實例說明本發明,分配係數係 定義爲某種物質在醇萃取相的濃度(重量%)及在水性殘液相 的濃度(重量%)之商。This standard is applicable to Chinese national standard (€ milk) 8 4 specifications (210, / 297 mm) TgT (Please read the precautions on the back before filling this page), order 496862 A7 B7_ V. Description of the invention (6) (i) An aqueous mixture containing 6-aminohexanoic acid, 6-aminohexamidine and its individual oligomers is reacted in a liquid phase in a reactor at 270 to 350 ° C to form ε-caprolactam. amine. (ii) Separating ammonia gas from the obtained aqueous mixture to a concentration of less than 0.1% by weight. (iii) Extraction of ε-caprolactam from the aqueous mixture obtained in step (Π) via the method according to the present invention. , Resulting in the formation of residual liquid phase and alcohol extraction liquid phase. (iv) contacting the aqueous residual liquid phase with the vapor to remove any dissolved alcohol solvent from the residual liquid phase. (v) recovering the aqueous phase obtained in step (iv) to step (i). (vi) ε-caprolactam is separated from the alcohol phase, and the resulting alcohol solvent is repeatedly used in step (iii). The temperature in step ⑴ is preferably 270 to 350 ° C, and more preferably higher than 290 ° C. The pressure in step ⑴ is preferably 5.0 to 20 MPa. Generally, the pressure will be greater than or equal to the pressure obtained by the liquid reaction mixture and the use temperature. . Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page). An example of a possible process diagram for the above specific embodiment is described in FIG. 1. The starting materials are fed to the cyclization reactor (A), and the ammonia (c) is separated from the aqueous reactor effluent (b) in the distillation (B), and ε-caprolactam, 6-amine Aqueous liquid mixture (d) of hexanoic acid, 6-aminohexamidine and its individual oligomers is fed to an extraction column (C), and countercurrent water (g) is supplied in this column and at the same time Alcohol solvent (h) is also supplied, and the obtained alcohol extraction phase (e) is fed to the distillation column (D), where the lower boiling alcohol and dissolved water are separated via ⑴ and ε-caprolactam product ⑴, in The liquid / liquid separator (E) separates alcohol from water, resulting in countercurrent water (g) (depending on the paper size, the Chinese National Standard (CNS) A4 specification (210X297 mm) 7010 496862 A7 B7 V. Description of the invention (7) Need to contain the same alcohol) and alcohol solvent stream (h) (containing partially dissolved water as needed), and feed the aqueous residual liquid phase To the steam stripper (F) any alcohol present in rhenium and any excess water are separated via rhenium to separate 6-aminohexanoic acid, 6-aminohexamidine and its individual oligomers and as needed The small amount of ε-caprolactam obtained in the obtained aqueous mixture (k) was recovered to the reactor (A). The invention will now be illustrated by the following non-limiting examples. The partition coefficient is defined as the quotient of the concentration (wt%) of a substance in the alcohol extraction phase and the concentration (wt%) in the aqueous residual liquid phase.
實例I 將含15.5重量%ε —己內醯胺、5.2重量%6 —胺基己 酸、17.4重量%6 —胺基己醯胺及2.2重量%6 —胺基己酸之 寡聚物與3.4重量%6 —胺基己醯胺之寡聚物的100克水性 混合物與100克4 一甲基一 2 -戊醇在80 °C下充分混合, 經足夠長的時間使達到平衡。 經濟部中央標準局員工消費合作社印製 ε —己內醯胺的分配係數爲3.3 ,在醇相中沒有偵測到 6—胺基己酸及6—胺基己酸之寡聚物,6—胺基己醯胺的 分配係數爲0.45且6 -胺基己醯胺之寡聚物的分配係數爲 0.66。Example I An oligomer containing 15.5% by weight of ε-caprolactam, 5.2% by weight of 6-aminohexanoic acid, 17.4% by weight of 6-aminohexamidine and 2.2% by weight of 6-aminohexanoic acid, and 3.4 100 g of an aqueous mixture of an oligomer of 6-aminohexamidine is thoroughly mixed with 100 g of 4-monomethyl-2-pentanol at 80 ° C, and equilibrium is reached for a sufficient time. Printed by the Consumers' Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, the distribution coefficient of ε-caprolactam is 3.3. No oligomers of 6-aminocaproic acid and 6-aminocaproic acid were detected in the alcohol phase. The partition coefficient of aminohexamidine is 0.45 and the partition coefficient of 6-aminohexamidine oligomer is 0.66.
實例II 在垂直放置的脈動塡充萃取管柱(直徑2.5公分)中塡入 3米玻璃雷氏圈(6毫米),將水性產物進料塡入頂部下方1 米,在60 °C下將逆流水供應至頂部並從底部供應4 -甲基 ^紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) _ 1〇 '~ 496862 A7 B7 五、發明説明(8 ) 2 —戊醇,供應速率爲 水性產物進料 1.6 5公斤/小時 逆流水 〇. 3 1公斤/小時 4 一甲基一 2 —戊醇 1.10公斤/小時 組成爲: 水性產物進料 18.1重量%己內醯胺 1.28重量%6 -胺基己酸(6ACA) 0.73重量%6 —胺基己醯胺(6ACAM) 2.89重量%6ACA及6ACAM之寡聚物。 在醇相頂部(約15重量%水)所得的成份爲 19.1重量%己內醯胺(99.6%產率) <0.01重量%6 —胺基己酸 <0.01重量%6 -胺基己醯胺 <0.01重量%寡聚物 經濟部中央標準局員工消費合作社印製 損失至醇相的6-胺基己醯胺、6-胺基S酸及寡聚物 低於1 %。 仍然存在於所得水相中的ε-己內醯胺,當此混合物在 製程中重複使用並將6ACA、6ACAM及寡聚物轉化成ε-己內醯胺時,不能視爲損失。 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) -11 -Example II: Put a 3m glass Reinforced circle (6mm) into a pulsating filled extraction column (2.5cm in diameter) placed vertically, feed the aqueous product 1m below the top, and countercurrently at 60 ° C. Water is supplied to the top and 4 -methyl ^ is supplied from the bottom. The paper size is in accordance with Chinese National Standard (CNS) A4 (210X297 mm) _ 1〇 '~ 496862 A7 B7 V. Description of the invention (8) 2-pentanol, supply The rate is 1.6 5 kg / hr of countercurrent water for water product feed. 0.3 1 kg / hr of 4 monomethyl-2-pentanol 1.10 kg / hr. The composition is: 18.1% by weight of the aqueous product. Caprolactam 1.28% by weight. 6-Aminohexanoic acid (6ACA) 0.73% by weight 6-Aminohexanamine (6ACAM) 2.89% by weight of 6ACA and 6ACAM oligomers. On the top of the alcohol phase (approximately 15% by weight of water), the content obtained was 19.1% by weight of caprolactam (99.6% yield) < 0.01% by weight of 6-aminohexanoic acid < 0.01% by weight of 6-aminohexanone Amine < 0.01% by weight of oligomers The Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs printed less than 1% of 6-aminohexamidine, 6-amino S acid and oligomers that had been lost to the alcohol phase. Ε-caprolactam, which is still present in the resulting aqueous phase, cannot be considered a loss when this mixture is reused in the process and 6ACA, 6ACAM and oligomers are converted to ε-caprolactam. This paper size applies to China National Standard (CNS) A4 specification (210X297 mm) -11-
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL1997/000033 WO1997030028A2 (en) | 1996-02-17 | 1997-02-05 | Recovery of epsilon-caprolactam from aqueous mixtures |
Publications (1)
Publication Number | Publication Date |
---|---|
TW496862B true TW496862B (en) | 2002-08-01 |
Family
ID=19866175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW086101201A TW496862B (en) | 1997-02-05 | 1997-08-16 | Recovery of epsi-caprolactam |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW496862B (en) |
-
1997
- 1997-08-16 TW TW086101201A patent/TW496862B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4115530A (en) | Process for obtaining gaseous hydrogen chloride from dilute, aqueous hydrochloric acid | |
KR100604507B1 (en) | Process for the continuous purification of crude ?-caprolactam | |
JP2004521923A (en) | Method for recovering and purifying caprolactam from organic solvents | |
KR100518073B1 (en) | PROCESS TO CONTINUOUSLY PREPARE AN AQUEOUS MIXTURE OF ε-CAPROLACTAM AND ε-CAPROLACTAM PRECURSORS | |
TW496862B (en) | Recovery of epsi-caprolactam | |
US5780623A (en) | Process to prepare ε-caprolactam from 6-aminocaproic acid | |
EP1175396B1 (en) | Process for the preparation of epsilon-caprolactam | |
KR100446372B1 (en) | PROCESS TO SEPARATE ε-CAPROLACTAM FROM 6-AMINOCAPROAMIDE AND 6-AMINOCAPROAMIDE OLIGOMERS | |
EP0891327B1 (en) | Recovery of epsilon-caprolactam from aqueous mixtures | |
TW499424B (en) | Process for the preparation of a mixture of ε-caprolactam, 6-aminocaproic acid and 6-aminocaproamide | |
EP1054864B1 (en) | Process for the preparation of epsilon-caprolactam | |
EP0826665A1 (en) | Recovery of epsilon-caprolactam from aqueous mixtures | |
JPH0455430B2 (en) | ||
KR20040011490A (en) | PROCESS FOR THE PREPARATION OF ε-CAPROLACTAM | |
PL52763B1 (en) | ||
SE186689C1 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4A | Issue of patent certificate for granted invention patent | ||
MM4A | Annulment or lapse of patent due to non-payment of fees |